Literature DB >> 10944518

The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats.

C Cabrele1, M Langer, R Bader, H A Wieland, H N Doods, O Zerbe, A G Beck-Sickinger.   

Abstract

The first Y(5) receptor-selective analog of neuropeptide Y (NPY), [Ala(31),Aib(32)]NPY, has been developed and biologically characterized. Using competition binding assays on cell lines that express different Y receptors, we determined the affinity of this analog to be 6 nm at the human Y(5) receptor, >500 nm at the Y(1) and Y(2) receptors, and >1000 nm at the Y(4) receptor. Activity studies performed in vitro using a cAMP enzyme immunoassay, and in vivo using food intake studies in rats, showed that the peptide acted as an agonist. Further peptides obtained by the combination of the Ala(31)-Aib(32) motif with chimeric peptides containing segments of NPY and pancreatic polypeptide displayed the same selectivity and even higher affinity (up to 0.2 nm) for the Y(5) receptor. In vivo administration of the new Y(5) receptor-selective agonists significantly stimulated feeding in rats. The NMR solution structures of NPY and [Ala(31),Aib(32)]NPY showed a different conformation in the C-terminal region, where the alpha-helix of NPY was substituted by a more flexible, 3(10)-helical turn structure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944518     DOI: 10.1074/jbc.M000626200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  The first reporter gene assay on living cells: green fluorescent protein as reporter gene for the investigation of Gi-protein coupled receptors.

Authors:  Michaela C Dinger; Annette G Beck-Sickinger
Journal:  Mol Biotechnol       Date:  2002-05       Impact factor: 2.695

2.  Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs.

Authors:  Anne Lecklin; Ingrid Lundell; Suvi Salmela; Pekka T Männistö; Annette G Beck-Sickinger; Dan Larhammar
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

3.  BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.

Authors:  Yvan Dumont; Pierrette Gaudreau; Manuela Mazzuferi; Daniel Langlois; Jean-Guy Chabot; Alain Fournier; Michele Simonato; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

4.  NPY Y1 receptor is involved in ghrelin- and fasting-induced increases in foraging, food hoarding, and food intake.

Authors:  Erin Keen-Rhinehart; Timothy J Bartness
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-01-04       Impact factor: 3.619

5.  The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.

Authors:  P C Yannielli; M E Harrington
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 6.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

7.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

8.  Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.

Authors:  Helen M Cox; Iain R Tough
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

9.  Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema.

Authors:  Yvan Dumont; Emmanuel Moyse; Alain Fournier; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2007-09-18       Impact factor: 3.444

10.  Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.

Authors:  Jennifer M Rojas; John M Stafford; Sanaz Saadat; Richard L Printz; Annette G Beck-Sickinger; Kevin D Niswender
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.